Bio-Techne (TECH) Retained Earnings (2009 - 2026)
Bio-Techne's (TECH) quarterly Retained Earnings came in at $1.1 billion in Q1 2026, up 1495.69% year-on-year from $71.8 million in Q1 2025, and up 3.47% quarter-over-quarter from $1.1 billion in Q4 2025.
Bio-Techne (TECH) Retained Earnings (2009 - 2026) Analysis & Trends
Bio-Techne's Retained Earnings history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- On a quarterly basis, Retained Earnings rose 1495.69% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 1495.69% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 19.56% from the prior year.
- Retained Earnings advanced to $1.1 billion in Q1 2026 per TECH's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.3 billion in Q3 2023 and bottomed at -$91.8 million in Q3 2022.
- The 5-year median for Retained Earnings is $1.1 billion (2025), against an average of $671.2 million.
- Across the five-year window, Retained Earnings plunged 106.93% in 2022 and soared 2106.0% in 2024, its largest moves.
- Year by year, Retained Earnings stood at $1.2 billion in 2022, then increased by 5.12% to $1.3 billion in 2023, then advanced by 2.01% to $1.3 billion in 2024, then decreased by 13.98% to $1.1 billion in 2025, then grew by 3.47% to $1.1 billion in 2026.
- Per Business Quant, the three latest TECH Retained Earnings figures stand at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 1.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Bn |
| Dec 31, 2025 | 1.11 Bn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | -82.05 Mn |
| Dec 31, 2024 | 1.29 Bn |
| Sep 30, 2024 | -60.09 Mn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | -75.31 Mn |
| Dec 31, 2023 | 1.26 Bn |
| Sep 30, 2023 | 1.33 Bn |
| Jun 30, 2023 | -66.06 Mn |
| Mar 31, 2023 | -73.55 Mn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | -91.81 Mn |
| Jun 30, 2022 | -75.20 Mn |
| Mar 31, 2022 | 1.13 Bn |
| Dec 31, 2021 | 1.15 Bn |
| Sep 30, 2021 | -64.22 Mn |
| Jun 30, 2021 | 1.09 Bn |